2026. Bimekizumab Safety in Patients with Psoriasis Achieving Complete Skin Clearance: 4-year Analysis from 5 Phase 3/3b Trials. SKIN The Journal of Cutaneous Medicine. 10, 2 (Mar. 2026), s757. DOI:https://doi.org/10.25251/v6wwxw80.